Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling

Reproduction

Volumn 130, Issue 5, 2005, Pages 751-758

  Margalit, Kate A ^a   Cowan, Robert G ^a   Harman, Rebecca M ^a   Quirk, Susan M ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOMYCIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DAUNORUBICIN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MESSENGER RNA; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER LOCALIZATION; CELL TYPE; CONTROLLED STUDY; COW; EPITHELIUM CELL; FEMALE; NONHUMAN; OVARIAN SURFACE EPITHELIAL CELL; OVARY CANCER; OVARY CELL; OVARY FOLLICLE; OVULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANISOMYCIN; ANTIGENS, CD95; APOPTOSIS; CASPASES; CATTLE; CELL SURVIVAL; CELLS, CULTURED; DAUNORUBICIN; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FEMALE; MEMBRANE GLYCOPROTEINS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAINING AND LABELING; TUMOR NECROSIS FACTORS;

ANIMALIA; BOVINAE;

EID: 27844555387     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.00816     Document Type: Article

References (36)

1. Baldwin RL, Tran H & Karlan BY 1999 Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis. Gynecologic Oncology 74 265-271.
2. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
3. Doraiswamy V, Parrott JA & Skinner MK 2000 Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer. Biology of Reproduction 63 789-796.
4. Faris M, Kokot N, Latinis K, Kasibhatla S, Green DR, Koretzky GA & Nel A 1998 The c-jun n-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by upregulating Fas ligand expression. Journal of Immunology 160 134-144.
5. Friesen C, Herr I, Krammer PH & Debatin K-M 1996 Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine 2 574-577.
6. Garban HJ & Bonavida B 1999 Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecologic Oncology 73 257-264.
7. Hengartner MO 2000 The biochemistry of apoptosis. Nature 407 770-776.
8. Hsu S-C, Gavrilin MA, Tsai M-H, Han j & Lai M-Z 1999 p38 mitogen-activated protein kinase is involved in Fas ligand expression. Journal of Biological Chemistry 274 25769-25776.
9. Hu C-L, Cowan RG, Harman RM, Porter DA & Quirk SM 2001 Apoptosis of bovine granulosa cells after serum withdrawal is mediated by Fas antigen (CD95) and Fas ligand. Biology of Reproduction 64 518-526.
10. Imai A, Tagaki A, Horibe S, Takagi H & Tamaya T 1998 Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. Journal of Clinical Endocrinology and Metabolism 83 427-431.
11. Leppã S & Bohmann D 1999 Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18 6158-6162.
12. Mansat-De Mas V, Bezombes C, Quillet-Mary A, Bettaïeb A, De Thonel D'orgeix A, Laurent G & Jaffrézou J-P 1999 Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Molecular Pharmacology 56 867-874.
13. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, et al. 2003 Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. Journal of Biological Chemistry 278 19245-19256.
14. Morimoto H, Yonehara S & Bonavida B 1993 Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Research 53 2591-2596.
15. Murdoch WJ 1995 Programmed cell death in preovulatory ovine follicles. Biology of Reproduction 53 8-12.
16. Murdoch WJ, Colgin DC & Ellis JA 1997 Role of tumor necrosis factor-α in the ovulatory mechanism of ewes. Journal of Animal Science 75 1601-1605.
17. Murdoch WJ & McDonnel AC 2002 Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123 743-750.
18. Park J, Kim I, Oh YJ, Lee K, Han P-L & Choi E-J 1997 Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. Journal of Biological Chemistry 272 16725-16728.
19. Parrott JA, Kim G & Skinner MK 2000a Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biology of Reproduction 62 1600-1609.
20. Parrott JA, Mosher R, Kim G & Skinner MK 2000b Autocrine interactions of keratinocyte growth factor, hepatocyte growth factor, and kit-ligand in the regulation of normal ovarian surface epithelial cells. Endocrinology 141 2532-2539.
21. Parrott JA & Skinner MK 2000 Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer. Biology of Reproduction 62 491-500.
22. Porter DA, Vickers SL, Cowan RG, Huber SC & Quirk SM 2000 Expression and function of Fas antigen vary in bovine granulosa and theca cells during ovarian follicular development and atresia. Biology of Reproduction 62 62-66.
23. Porter DA, Harman RM, Cowan RG & Quirk SM 2001 Relationship of Fas ligand expression and atresia during bovine follicular development. Reproduction 121 561-566.
24. Quirk SM, Cowan RG & Huber SH 1997 Fas antigen-mediated apoptosis of ovarian surface epithelial cells. Endocrinology 138 4558-4566.
25. Quirk SM, Harman RM & Cowan RG 2000 Regulation of Fas antigen (Fas, CD95)-mediated apoptosis of bovine granulosa cells by serum and growth factors. Biology of Reproduction 63 1278-1284.
26. Quirk SM, Cowan RG, Harman RM, Hu C-L & Porter DA 2004 Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. Journal of Animal Science 82 E40-E52.
27. Sapi E, Brown WD, Aschkenazi S, Lim C, Munoz A, Kacinski BM, Rutherford T & Mor G 2002 Regulation of Fas ligand expression by estrogen in normal ovary. Journal of the Society for Gynecologic Investigation 9 243-250.
28. Schneiderman D, Kim J-M, Senterman M & Tsang BK 1999 Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian epithelial cancer cells. Apoptosis 4 271-282.
29. Shifrin VI & Anderson P 1999 Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. Journal of Biological Chemistry 274 13985-13992.
30. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW & Cohen GM 1996 Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochemical Journal 315 21-24.
31. Syed V & Ho S-M 2003 Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene 22 6883-6890.
32. Talbot P, Martin GG & Ashby H 1987 Formation of the rupture site in preovulatory hamster and mouse follicles: loss of the surface epithelium. Gamete Research 17 287-302.
33. Van Haaften-Day C, Russell P, Davies S, King NJC & Tattersall MHN 2003 Expression of Fas and FasL in human serous ovarian epithelial tumors. Human Pathology 34 74-79.
34. Vickers SL, Cowan RG, Harman RM, Porter DA & Quirk SM 2000 Expression and activity of the Fas antigen in bovine ovarian follicle cells. Biology of Reproduction 62 54-61.
35. Wakahara Y, Nawa A, Okamoto T, Hayakawa A, Kikkawa F, Suganama N et al. 1997 Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro. Oncology 54 48-54.
36. Wiesen J & Werb Z 2000 Proteinases, cell cycle regulation, and apoptosis during mammary gland involution. Molecular Reproduction and Development 56 534-540.